Paul Quinlan
2021
In 2021, Paul Quinlan earned a total compensation of $656.3K as General Counsel at Cymabay Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $152,872 |
|---|---|
| Option Awards | $103,380 |
| Salary | $394,000 |
| Other | $6,020 |
| Total | $656,272 |
Quinlan received $394K in salary, accounting for 60% of the total pay in 2021.
Quinlan also received $152.9K in non-equity incentive plan, $103.4K in option awards and $6K in other compensation.
Rankings
In 2021, Paul Quinlan's compensation ranked 10,086th out of 12,405 executives tracked by ExecPay. In other words, Quinlan earned more than 18.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,086 out of 12,405 | 19th |
Division Manufacturing | 4,463 out of 5,494 | 19th |
Major group Chemicals And Allied Products | 1,991 out of 2,369 | 16th |
Industry group Drugs | 1,767 out of 2,090 | 16th |
Industry Pharmaceutical Preparations | 1,315 out of 1,537 | 14th |
Source: SEC filing on April 19, 2023.
Quinlan's colleagues
We found four more compensation records of executives who worked with Paul Quinlan at Cymabay Therapeutics in 2021.